Search research articles
Contact Us
Filters
Showing results (161-170 of 219) with videos related to
Page
of 22
Sort By:
Oncogene
|
January 11, 2007
Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells
V Appierto, M G Villani, E Cavadini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2012
Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series
R Fruscio, S Corso, L Ceppi, et al.
Brain : a Journal of Neurology
|
November 25, 2006
Surgical treatment of drug-resistant nocturnal frontal lobe epilepsy
L Nobili, S Francione, R Mai, et al.
Brain : a Journal of Neurology
|
July 24, 2002
Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome
L Tassi, N Colombo, R Garbelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2004
Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy
G Cavaletti, G Bogliun, L Marzorati, et al.
Gynecologic Oncology
|
December 14, 2012
A Phase II, randomized, double-blind study of zibotentan (ZD4054) in combination with carboplatin/paclitaxel versus placebo in combination with carboplatin/paclitaxel in patients with advanced ovarian cancer sensitive to platinum-based chemotherapy (AGO-OVAR 2.14)
F Cognetti, A Bagnato, N Colombo, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1988
The disposition of carboplatin in ovarian cancer patients
R C Gaver, N Colombo, M D Green, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2022
Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
A Oaknin, T J Bosse, C L Creutzberg, et al.
British Journal of Cancer
|
February 14, 2013
Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial
N Colombo, D S McMeekin, P E Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1994
European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion
E A Eisenhauer, W W ten Bokkel Huinink, K D Swenerton, et al.
Page
of 22
Search research articles
Search
Showing results (161-170 of 219) with videos related to
Sort By:
Page
of 22
Oncogene
|
January 11, 2007
Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells
V Appierto, M G Villani, E Cavadini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2012
Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series
R Fruscio, S Corso, L Ceppi, et al.
Brain : a Journal of Neurology
|
November 25, 2006
Surgical treatment of drug-resistant nocturnal frontal lobe epilepsy
L Nobili, S Francione, R Mai, et al.
Brain : a Journal of Neurology
|
July 24, 2002
Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome
L Tassi, N Colombo, R Garbelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2004
Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy
G Cavaletti, G Bogliun, L Marzorati, et al.
Gynecologic Oncology
|
December 14, 2012
A Phase II, randomized, double-blind study of zibotentan (ZD4054) in combination with carboplatin/paclitaxel versus placebo in combination with carboplatin/paclitaxel in patients with advanced ovarian cancer sensitive to platinum-based chemotherapy (AGO-OVAR 2.14)
F Cognetti, A Bagnato, N Colombo, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1988
The disposition of carboplatin in ovarian cancer patients
R C Gaver, N Colombo, M D Green, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2022
Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
A Oaknin, T J Bosse, C L Creutzberg, et al.
British Journal of Cancer
|
February 14, 2013
Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial
N Colombo, D S McMeekin, P E Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1994
European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion
E A Eisenhauer, W W ten Bokkel Huinink, K D Swenerton, et al.
Page
of 22